z-logo
open-access-imgOpen Access
Opioid medication in the palliative care of motor neurone disease
Author(s) -
David J. Oliver
Publication year - 1998
Publication title -
palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.989
H-Index - 106
eISSN - 1477-030X
pISSN - 0269-2163
DOI - 10.1191/026921698677326556
Subject(s) - medicine , palliative care , opioid , morphine , motor neurone disease , retrospective cohort study , anesthesia , disease , intensive care medicine , amyotrophic lateral sclerosis , nursing , receptor
In the palliative care of patients with motor neurone disease (MND) symptoms are encountered that can be helped by the use of strong opioid medication. A retrospective survey of the 32 patients dying of MND at the Wisdom Hospice who required opioids showed that 75% received oral opioids, 94% received parenteral opioids and 72% received both oral and parenteral opioids. The median oral morphine dose was 60 mg/24 h, with a median duration of 51 days and the median parenteral dose was 180 mg/24 h with a median duration of use of three days. The results show that strong opioids can be used safely and effectively in the palliative care of patients with MND.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom